Zevaquenabant
Zevaquenabant ((S) -MRI-1867) is an orally active, peripherally restricted dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS) . It has demonstrated efficacy in preclinical models for mitigating renal injury and fibrosis associated with obesity-induced chronic kidney disease (CKD) .
Product Specifications
CAS Number
1998760-00-1
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Smiles
CC (=N) N=C (NS (=O) (=O) c1ccc (cc1) C (F) (F) F) N1C[C@@H] (C (=N1) c1ccc (Cl) cc1) c1ccccc1 |w:3.2, c:23|
Molecular Formula
C25H21ClF3N5O2S
Molecular Weight
547.98
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP52398_P050 100 µL
CRY2 antibody - N-terminal region (ARP52398_P050)
Sign In for Pricing
View Details